.png){kind=small}
.png){kind=small}
BackTable / Urology / Topic / Condition
Prostate Cancer
Learn more on the BackTable Urology Podcast
BackTable is a knowledge resource for physicians by physicians. Get practical advice on Prostate Cancer and how to build your practice by listening to the BackTable Urology Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Prostate Cancer Podcasts
Listen to leading physicians discuss prostate cancer on the BackTable Urology Podcast. Get tips, tricks, and expert guidance from your peers and level up your practice.
Episode #200
Biochemical recurrence of prostate cancer can be difficult to diagnose and treat. In this episode of BackTable Urology, where Dr. Aditya Bagrodia hosts Dr. Amar Kishan, a genitourinary radiation oncologist at UCLA, to discuss the complexities of biochemical recurrence and local failure after radiation therapy for prostate cancer.
Episode #191
What does recent research say about the role of perirectal spacers in prostate cancer treatment? In this episode of the BackTable Urology Podcast, host Dr. Jose Silva discusses the use of perirectal spacers for prostate radiotherapy with guests Dr. Eric Chenven, Chief of Urology at Broward Health Medical Center, and Dr. Nadim Nasr, a radiation oncologist at Arlington Radiation Oncology.
Episode #189
Did you know that robotic prostatectomy has its roots in both the immigrant experience and the renowned manufacturing legacy of Detroit? In this episode of BackTable Urology, Dr. Mani Menon, a pioneer in robotic surgery, joins Dr. Aditya Bagrodia to discuss the development of robotic prostatectomy technology.
Episode #188
What is the role of testosterone therapy in prostate cancer? Urologist Dr. Abraham Morgentaler of Beth Israel Deaconess Medical Center and Harvard Medical School joins host Dr. Jose Silva to discuss the evolution of testosterone therapies, modern testosterone treatments, and how to integrate testosterone replacement therapy into your practice.
Episode #172
In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.
Episode #170
In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).
Episode #161
This week on BackTable Urology, Dr. Suzette Sutherland (University of Washington) and Dr. Drew Peterson (Duke University) explore the psychological and clinical challenges faced by genitourinary cancer survivors dealing with the urological consequences of cystectomy and urinary diversion.
Episode #149
This week on BackTable Urology, urologic oncologist Dr. Bogdana Schmidt (University of Utah) hosts a discussion with medical oncology experts Dr. Rana McKay (UC San Diego) and Dr. Neeraj Agarwal (University of Utah) on recent clinical trials from bladder, kidney, and prostate cancer research presented at the 2023 European Society for Medical Oncology (ESMO) Meeting.
Episode #123
This week on BackTable Urology, Dr. Juan Javier-Desloges, a urologic oncologist at UC San Diego, interviews Dr. Neil Taunk, a radiation oncologist leading the Brachytherapy and Procedural Radiation program at the University of Pennsylvania, about his experience with using SpaceOAR rectal spacer for prostate cancer radiotherapy.
Episode #114
This week on the BackTable Urology Podcast, Dr. Jose Silva discusses sexual health with Dr. Arthur “Bud” Burnett, professor of urology at John Hopkins University, with an emphasis on the importance of preventative medicine in improving sexual health and different treatments for erectile dysfunction.
Episode #94
On this episode of BackTable Urology, Dr. Aditya Bagrodia, Dr. Daniel Costa (UT Southwestern), and Dr. Xiaosong Meng (UT Southwestern) discuss patient selection and procedure for TULSA-PRO, a new transurethral ultrasound ablation system that incorporates real-time MR imaging, as a focal treatment option for prostate cancer.
Prostate Cancer Articles
Read our exclusive BackTable Urology Articles for quick insights on prostate cancer, provided by physicians for physicians.
Compared to resection or radiation, focal therapy may offer a less invasive and more precise treatment option for prostate cancer patients. Who is the ideal patient for prostate cancer focal therapy? Which focal therapy modality is best? How do we optimize care after focal therapy to ensure that recurrence is managed effectively?
Advancements in genomics and imaging are transforming prostate cancer diagnosis and treatment by reducing overdiagnosis and personalizing treatment. Learn more about the integration of genomic tests and imaging techniques to help distinguish between benign conditions and clinically significant cancers.
A variety of prostate cancer screening tools can be used to aid in patient selection for biopsy, in addition to guiding prostate cancer risk stratification. Urologists Dr. Jose Silva and Dr. Ali Kasraeian detail the role of multiparametric MRI and molecular testing in the early detection of prostate cancer.
The digital rectal exams and PSA blood tests both possess limitations as prostate cancer screening tools. Urologists Dr. Jose Silva and Dr. Ali Kasraeian share insight on society guidelines and research for PSA screening, decision-making, and patient education through a detailed risk-benefit analysis of prostate cancer detection.
Radical therapy remains the cornerstone in the treatment of high-risk prostate cancer, encompassing modalities such as radical prostatectomy and brachytherapy. Criteria for the high-risk prostate cancer designation typically include a Gleason score ranging from 8 to 10, grade 4 or 5, or PSA levels surpassing 20.
Urologist Dr. Jose Silva and endocrinologist Dr. Rodrigo Valderrábano dive into the groundbreaking research that’s exploring the viability of testosterone treatment in prostate cancer survivors. The doctors discuss the importance of proper patient selection and preliminary findings from Dr. Valderrábano’s clinical trial.
Prostate Cancer Tools
Check out prostate cancer apps, calculators, and decision aids to assist you in your day to day practice.
Disclaimer: The Materials available on https://www.BackTable.com/ are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Podcasts
Articles
Prostate Cancer Focal Therapy: Who is the Ideal Patient?
The Modern Role of Genomics & Imaging in Prostate Cancer Diagnosis & Treatment
Active Surveillance for Prostate Cancer: A Tailored Approach
Contributors
Dr. Neeraj Agarwal
Dr. David Albala
Dr. Matthew Allaway
Dr. Matthew Allaway
Dr. Bud Burnett
Dr. Jeff Cadeddu